Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase

20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 ω-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It is released from preglomerular microvessels by ANG II and is subject to metabolism by cyclooxygenase (COX). Because low-salt (LS) intake stimu...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of physiology. Renal physiology Vol. 284; no. 3; pp. F474 - F479
Main Authors Cheng, Monica K., McGiff, John C., Carroll, Mairead A.
Format Journal Article
LanguageEnglish
Published United States 01.03.2003
Subjects
Online AccessGet full text
ISSN1931-857X
1522-1466
DOI10.1152/ajprenal.00239.2002

Cover

Abstract 20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 ω-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It is released from preglomerular microvessels by ANG II and is subject to metabolism by cyclooxygenase (COX). Because low-salt (LS) intake stimulates the renin-angiotensin system and induces renal cortical COX-2 expression, we examined 20-HETE release from renal arteries (interlobar and arcuate and interlobular arteries) obtained from 6- to 7-wk-old male Sprague-Dawley rats fed either normal salt (0.4% NaCl) or LS (0.05% NaCl) diets for 10 days. With normal salt intake, the levels of 20-HETE recovered were similar in arcuate and interlobular arteries and interlobar arteries: 30.1 ± 8.5 vs. 24.6 ± 5.3 ng · mg protein −1 · 30 min −1 , respectively. An LS diet increased 20-HETE levels in the incubate of either arcuate and interlobular or interlobar renal arteries only when COX was inhibited. Addition of indomethacin (10 μM) to the incubate of arteries obtained from rats fed an LS diet resulted in a two- to threefold increase in 20-HETE release from arcuate and interlobular arteries, from 39.1 ± 13.2 to 101.8 ± 42.6 ng · mg protein −1 · 30 min −1 ( P < 0.03), and interlobar arteries, from 31.7 ± 15.1 to 61.9 ± 29.4 ng · mg protein −1 · 30 min −1 ( P < 0.05) compared with release of 20-HETE when COX was not inhibited. An LS diet enhanced vascular expression of cytochrome P-4504A and COX-2 in arcuate and interlobular arteries; COX-1 was unaffected. Metabolism of 20-HETE by COX is proposed to represent an important regulatory mechanism in setting preglomerular microvascular tone.
AbstractList 20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 omega-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It is released from preglomerular microvessels by ANG II and is subject to metabolism by cyclooxygenase (COX). Because low-salt (LS) intake stimulates the renin-angiotensin system and induces renal cortical COX-2 expression, we examined 20-HETE release from renal arteries (interlobar and arcuate and interlobular arteries) obtained from 6- to 7-wk-old male Sprague-Dawley rats fed either normal salt (0.4% NaCl) or LS (0.05% NaCl) diets for 10 days. With normal salt intake, the levels of 20-HETE recovered were similar in arcuate and interlobular arteries and interlobar arteries: 30.1 +/- 8.5 vs. 24.6 +/- 5.3 ng. mg protein(-1). 30 min(-1), respectively. An LS diet increased 20-HETE levels in the incubate of either arcuate and interlobular or interlobar renal arteries only when COX was inhibited. Addition of indomethacin (10 microM) to the incubate of arteries obtained from rats fed an LS diet resulted in a two- to threefold increase in 20-HETE release from arcuate and interlobular arteries, from 39.1 +/- 13.2 to 101.8 +/- 42.6 ng. mg protein(-1). 30 min(-1) (P < 0.03), and interlobar arteries, from 31.7 +/- 15.1 to 61.9 +/- 29.4 ng. mg protein(-1). 30 min(-1) (P < 0.05) compared with release of 20-HETE when COX was not inhibited. An LS diet enhanced vascular expression of cytochrome P-4504A and COX-2 in arcuate and interlobular arteries; COX-1 was unaffected. Metabolism of 20-HETE by COX is proposed to represent an important regulatory mechanism in setting preglomerular microvascular tone.20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 omega-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It is released from preglomerular microvessels by ANG II and is subject to metabolism by cyclooxygenase (COX). Because low-salt (LS) intake stimulates the renin-angiotensin system and induces renal cortical COX-2 expression, we examined 20-HETE release from renal arteries (interlobar and arcuate and interlobular arteries) obtained from 6- to 7-wk-old male Sprague-Dawley rats fed either normal salt (0.4% NaCl) or LS (0.05% NaCl) diets for 10 days. With normal salt intake, the levels of 20-HETE recovered were similar in arcuate and interlobular arteries and interlobar arteries: 30.1 +/- 8.5 vs. 24.6 +/- 5.3 ng. mg protein(-1). 30 min(-1), respectively. An LS diet increased 20-HETE levels in the incubate of either arcuate and interlobular or interlobar renal arteries only when COX was inhibited. Addition of indomethacin (10 microM) to the incubate of arteries obtained from rats fed an LS diet resulted in a two- to threefold increase in 20-HETE release from arcuate and interlobular arteries, from 39.1 +/- 13.2 to 101.8 +/- 42.6 ng. mg protein(-1). 30 min(-1) (P < 0.03), and interlobar arteries, from 31.7 +/- 15.1 to 61.9 +/- 29.4 ng. mg protein(-1). 30 min(-1) (P < 0.05) compared with release of 20-HETE when COX was not inhibited. An LS diet enhanced vascular expression of cytochrome P-4504A and COX-2 in arcuate and interlobular arteries; COX-1 was unaffected. Metabolism of 20-HETE by COX is proposed to represent an important regulatory mechanism in setting preglomerular microvascular tone.
20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 ω-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It is released from preglomerular microvessels by ANG II and is subject to metabolism by cyclooxygenase (COX). Because low-salt (LS) intake stimulates the renin-angiotensin system and induces renal cortical COX-2 expression, we examined 20-HETE release from renal arteries (interlobar and arcuate and interlobular arteries) obtained from 6- to 7-wk-old male Sprague-Dawley rats fed either normal salt (0.4% NaCl) or LS (0.05% NaCl) diets for 10 days. With normal salt intake, the levels of 20-HETE recovered were similar in arcuate and interlobular arteries and interlobar arteries: 30.1 ± 8.5 vs. 24.6 ± 5.3 ng · mg protein −1 · 30 min −1 , respectively. An LS diet increased 20-HETE levels in the incubate of either arcuate and interlobular or interlobar renal arteries only when COX was inhibited. Addition of indomethacin (10 μM) to the incubate of arteries obtained from rats fed an LS diet resulted in a two- to threefold increase in 20-HETE release from arcuate and interlobular arteries, from 39.1 ± 13.2 to 101.8 ± 42.6 ng · mg protein −1 · 30 min −1 ( P < 0.03), and interlobar arteries, from 31.7 ± 15.1 to 61.9 ± 29.4 ng · mg protein −1 · 30 min −1 ( P < 0.05) compared with release of 20-HETE when COX was not inhibited. An LS diet enhanced vascular expression of cytochrome P-4504A and COX-2 in arcuate and interlobular arteries; COX-1 was unaffected. Metabolism of 20-HETE by COX is proposed to represent an important regulatory mechanism in setting preglomerular microvascular tone.
20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 omega-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It is released from preglomerular microvessels by ANG II and is subject to metabolism by cyclooxygenase (COX). Because low-salt (LS) intake stimulates the renin-angiotensin system and induces renal cortical COX-2 expression, we examined 20-HETE release from renal arteries (interlobar and arcuate and interlobular arteries) obtained from 6- to 7-wk-old male Sprague-Dawley rats fed either normal salt (0.4% NaCl) or LS (0.05% NaCl) diets for 10 days. With normal salt intake, the levels of 20-HETE recovered were similar in arcuate and interlobular arteries and interlobar arteries: 30.1 +/- 8.5 vs. 24.6 +/- 5.3 ng. mg protein(-1). 30 min(-1), respectively. An LS diet increased 20-HETE levels in the incubate of either arcuate and interlobular or interlobar renal arteries only when COX was inhibited. Addition of indomethacin (10 microM) to the incubate of arteries obtained from rats fed an LS diet resulted in a two- to threefold increase in 20-HETE release from arcuate and interlobular arteries, from 39.1 +/- 13.2 to 101.8 +/- 42.6 ng. mg protein(-1). 30 min(-1) (P < 0.03), and interlobar arteries, from 31.7 +/- 15.1 to 61.9 +/- 29.4 ng. mg protein(-1). 30 min(-1) (P < 0.05) compared with release of 20-HETE when COX was not inhibited. An LS diet enhanced vascular expression of cytochrome P-4504A and COX-2 in arcuate and interlobular arteries; COX-1 was unaffected. Metabolism of 20-HETE by COX is proposed to represent an important regulatory mechanism in setting preglomerular microvascular tone.
Author McGiff, John C.
Carroll, Mairead A.
Cheng, Monica K.
Author_xml – sequence: 1
  givenname: Monica K.
  surname: Cheng
  fullname: Cheng, Monica K.
  organization: Department of Pharmacology, New York Medical College, Valhalla, New York
– sequence: 2
  givenname: John C.
  surname: McGiff
  fullname: McGiff, John C.
  organization: Department of Pharmacology, New York Medical College, Valhalla, New York
– sequence: 3
  givenname: Mairead A.
  surname: Carroll
  fullname: Carroll, Mairead A.
  organization: Department of Pharmacology, New York Medical College, Valhalla, New York
BackLink https://www.ncbi.nlm.nih.gov/pubmed/12419775$$D View this record in MEDLINE/PubMed
BookMark eNp9kElPwzAQhS1URBf4BUgoJ24pXpIm5oYqNqkSEovEzbKdSXHlxsVOEfn3uBsHDpxmNPPe08w3RL3GNYDQOcFjQnJ6JRcrD420Y4wp42MayxEaxA1NSTaZ9GLPGUnLvHjvo2EIC4wxIZScoD6hGeFFkQ_Qy_MmIpG-BW9iQ3H60VXefXdgtAuyhdZLaJzRidSmSix8gQ3XiYf52srWuCZRXaI7bV30zGNYgFN0XEsb4GxfR-jt7vZ1-pDOnu4fpzezVDNO2jTHjJRQlUxRVutMYqVYzWmFM8mLuqCKZopzUCALWseLWVnncZRzolmVTTgboctd7sq7zzWEVixN0GCtbMCtgygoLzlhZRRe7IVrtYRKrLxZSt-JA4Yo4DuB9i4ED7XQpt1-F783VhAsNsjFAbnYIhcb5NHL_nh_4_9x_QD6PYgo
CitedBy_id crossref_primary_10_1038_sj_bjp_0705640
crossref_primary_10_1155_2015_149408
crossref_primary_10_1161_HYPERTENSIONAHA_107_105395
crossref_primary_10_3390_pharmaceutics9010009
crossref_primary_10_1007_s00424_013_1262_8
crossref_primary_10_1016_j_abb_2008_06_025
crossref_primary_10_1111_apha_13297
crossref_primary_10_1681_ASN_2014090868
crossref_primary_10_3390_biomedicines10020407
Cites_doi 10.1016/0003-2697(76)90527-3
10.1152/ajprenal.00265.2001
10.1152/ajprenal.1990.258.4.F781
10.1042/bj2380283
10.1074/jbc.M003505200
10.1016/S0021-9258(19)36671-2
10.1152/ajprenal.1992.262.1.F8
10.1152/ajprenal.1999.277.3.F360
10.1152/ajprenal.1998.274.1.F148
10.1152/ajprenal.2000.279.3.F544
10.1152/ajprenal.1992.262.4.F591
10.1016/S0021-9258(18)80115-6
10.1016/S0002-9343(70)80073-0
10.1016/S0021-9258(18)98897-6
10.1152/ajprenal.1994.266.6.F934
10.1016/0006-291X(92)91686-K
10.1016/S0022-3565(25)23636-9
10.1016/S0022-3565(25)11191-9
10.1152/ajprenal.1994.266.2.F275
10.1016/S0895-7061(01)02034-9
10.1152/ajpregu.1996.270.1.R217
10.1152/ajpregu.1996.271.4.R863
10.1172/JCI119640
10.1152/ajprenal.1998.274.3.F433
10.1161/01.RES.40.6.590
10.1038/ki.1997.234
10.1152/ajprenal.1998.274.3.F481
10.1161/01.RES.72.1.126
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1152/ajprenal.00239.2002
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1522-1466
EndPage F479
ExternalDocumentID 12419775
10_1152_ajprenal_00239_2002
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: HL-25394
– fundername: NHLBI NIH HHS
  grantid: HL-34300
GroupedDBID ---
23M
2WC
39C
53G
5GY
5VS
6J9
AAFWJ
AAYXX
ACPRK
ADBBV
AENEX
AFFNX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
C1A
CITATION
E3Z
EBS
EJD
EMOBN
F5P
GX1
H13
ITBOX
KQ8
OK1
P2P
PQQKQ
RAP
RHI
RPL
RPRKH
TR2
W8F
WOQ
XSW
YSK
4.4
8M5
BKKCC
CGR
CUY
CVF
DIK
ECM
EIF
NPM
RHF
7X8
ID FETCH-LOGICAL-c391t-50318ed83b23fc4a0bb3f92d04a97f72b24b99ebea72f12438f524b591c3d4693
ISSN 1931-857X
IngestDate Fri Jul 11 05:55:56 EDT 2025
Wed Feb 19 01:28:00 EST 2025
Sun Jul 06 05:05:49 EDT 2025
Thu Apr 24 23:08:17 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c391t-50318ed83b23fc4a0bb3f92d04a97f72b24b99ebea72f12438f524b591c3d4693
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 12419775
PQID 72989138
PQPubID 23479
ParticipantIDs proquest_miscellaneous_72989138
pubmed_primary_12419775
crossref_citationtrail_10_1152_ajprenal_00239_2002
crossref_primary_10_1152_ajprenal_00239_2002
PublicationCentury 2000
PublicationDate 2003-03-01
2003-Mar
20030301
PublicationDateYYYYMMDD 2003-03-01
PublicationDate_xml – month: 03
  year: 2003
  text: 2003-03-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle American journal of physiology. Renal physiology
PublicationTitleAlternate Am J Physiol Renal Physiol
PublicationYear 2003
References B20
B21
B22
B23
B24
B26
B27
B28
B29
Carroll MA (B6) 1992; 260
Schwartzman ML (B25) 1989; 264
Escalante B (B12) 1989; 248
Carroll MA (B7) 2001; 7
Capdevila JH (B2) 1992; 267
B30
B11
B13
B14
B15
B16
B17
B18
B19
B1
B3
B4
B5
B9
Carroll MA (B8) 1991; 266
References_xml – ident: B1
  doi: 10.1016/0003-2697(76)90527-3
– ident: B17
  doi: 10.1152/ajprenal.00265.2001
– ident: B26
  doi: 10.1152/ajprenal.1990.258.4.F781
– ident: B24
  doi: 10.1042/bj2380283
– ident: B18
  doi: 10.1074/jbc.M003505200
– volume: 267
  start-page: 21720
  year: 1992
  ident: B2
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)36671-2
– ident: B20
  doi: 10.1152/ajprenal.1992.262.1.F8
– ident: B13
  doi: 10.1152/ajprenal.1999.277.3.F360
– ident: B14
  doi: 10.1152/ajprenal.1998.274.1.F148
– ident: B9
  doi: 10.1152/ajprenal.2000.279.3.F544
– ident: B21
  doi: 10.1152/ajprenal.1992.262.4.F591
– volume: 264
  start-page: 11658
  year: 1989
  ident: B25
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)80115-6
– ident: B11
  doi: 10.1016/S0002-9343(70)80073-0
– volume: 266
  start-page: 12306
  year: 1991
  ident: B8
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)98897-6
– ident: B30
  doi: 10.1152/ajprenal.1994.266.6.F934
– ident: B22
  doi: 10.1016/0006-291X(92)91686-K
– volume: 248
  start-page: 229
  year: 1989
  ident: B12
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(25)23636-9
– volume: 260
  start-page: 104
  year: 1992
  ident: B6
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(25)11191-9
– ident: B29
  doi: 10.1152/ajprenal.1994.266.2.F275
– ident: B5
  doi: 10.1016/S0895-7061(01)02034-9
– ident: B15
  doi: 10.1152/ajpregu.1996.270.1.R217
– ident: B4
  doi: 10.1152/ajpregu.1996.271.4.R863
– ident: B23
  doi: 10.1172/JCI119640
– ident: B19
  doi: 10.1152/ajprenal.1998.274.3.F433
– ident: B27
  doi: 10.1161/01.RES.40.6.590
– ident: B3
  doi: 10.1038/ki.1997.234
– ident: B28
  doi: 10.1152/ajprenal.1998.274.3.F481
– ident: B16
  doi: 10.1161/01.RES.72.1.126
– volume: 7
  start-page: 567
  year: 2001
  ident: B7
  publication-title: Med Sci Monit
SSID ssj0001121
Score 1.8128124
Snippet 20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 ω-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It...
20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 omega-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels....
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage F474
SubjectTerms Animals
Blotting, Western
Cyclooxygenase 1
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors - pharmacology
Cytochrome P-450 CYP4A
Cytochrome P-450 Enzyme System - metabolism
Hydroxyeicosatetraenoic Acids - analysis
Hydroxyeicosatetraenoic Acids - metabolism
In Vitro Techniques
Indomethacin - pharmacology
Isoenzymes - metabolism
Kidney - blood supply
Male
Membrane Proteins
Mixed Function Oxygenases - metabolism
Prostaglandin-Endoperoxide Synthases - metabolism
Rats
Rats, Sprague-Dawley
Renal Artery - chemistry
Renal Artery - drug effects
Renal Artery - metabolism
Sodium, Dietary - pharmacology
Title Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase
URI https://www.ncbi.nlm.nih.gov/pubmed/12419775
https://www.proquest.com/docview/72989138
Volume 284
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAvE2xcytUPiJeRkdhOnPA2TSvTWMetlfoW-SpAXYK69KH8eo7tpOnExu0lqqw6jvydnJzL53MQesFFLBi3WUQ0txFjOotyKWgkpC0yrVyncs-2OMuOp-xkls4Gg5MN1tKykfvqx5XnSv4HVRgDXN0p2X9Adn1TGIDfgC9cAWG4_hXGn4yzJT0r0wW-wUX7stKOl2IA3wuwIpuFMFXtSrKqr3pv7ghCngK3CB3oHfRgfqqVmtcwC9bpcjVdXdoun7NRYMLHQnwwfn8vPEA_0pMFTNAhTmUo0cdSx-ptWwfSU3bWIdpDVwsyZEDGArSw0G2QtQtI0J6R1erQgiZRnvLZppIloRFcK010Q2WOWGjT86suT11tWPHN1fYEP8Qfw_Wckv7T1aXrz96Xo-npaTk5mk1uoJuEc5-yf_exrxwPdmUSGAbh4doKVLDI6yuWuGylXON6eBNkcgdtt74DPgiCcBcNTLWDdg8q0dTnK_wSf1jjsINujVvSxC767FHCnZjg68UEOzHBQUze4F5IsFzhy0JyD01HR5PD46jtpREpWiRNlDrlbXROJaFWMRFLSW1BdMxEwS0nkjBZFPBGC04s2Hw0tykMpUWiqGZZQe-jraquzEOEUy3ByckJN7llWoODITOZxLLIDY81tUNEur0rVVto3vU7mZfe4UxJ2W146TfcdUIlQ_RqPel7qLPy-78_70ApQR-6JJeoTL28KLlrKZDQfIgeBKz624GxCt5O-uiPcx-j271gP0FbzWJpnoLt2chnXqh-AnM8iZM
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Renal+arterial+20-hydroxyeicosatetraenoic+acid+levels%3A+regulation+by+cyclooxygenase&rft.jtitle=American+journal+of+physiology.+Renal+physiology&rft.au=Cheng%2C+Monica+K&rft.au=McGiff%2C+John+C&rft.au=Carroll%2C+Mairead+A&rft.date=2003-03-01&rft.issn=1931-857X&rft.volume=284&rft.issue=3&rft.spage=F474&rft_id=info:doi/10.1152%2Fajprenal.00239.2002&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1931-857X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1931-857X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1931-857X&client=summon